Top Blood Sugar Monitor Brands: Precision, Innovation, and Reliability!

Monitoring blood sugar levels is a crucial aspect of managing and maintaining one’s health, particularly for individuals living with diabetes. With technological advancements, a variety of brands now offer innovative and reliable blood sugar monitors designed to suit different preferences and medical needs. Some of the leading brands recognized for their accuracy and ease of use include Accu-Chek, OneTouch, and Bayer Contour, each offering unique features that enhance user experience. Interested in finding out which other brands are making waves in the blood sugar monitoring industry this year? Read on below to discover more.

Illustration of blood sugar monitor

Best brands of blood sugar monitor in 2025

Abbott FreeStyle Libre

Abbott's FreeStyle Libre has emerged as a leading brand in blood sugar monitoring, with its continuous glucose monitors (CGMs) achieving significant milestones. In 2022, the FreeStyle Libre generated $4.3 billion in sales, a 22% increase year over year, and the company aims to reach $10 billion in sales by 2028 with a compound annual growth rate of 15%. The system is used by over 1 million people across 44 countries and has become the No. 1 sensor-based glucose monitoring system worldwide. It features advanced capabilities such as real-time alarms for high or low glucose levels and integration with insulin pumps. The success of FreeStyle Libre is attributed to its pain-free, highly accurate, and cost-effective design. For more information about their continuous glucose monitoring system, visit FreeStyle Libre.

Dexcom

Dexcom, a leading producer of blood sugar monitors, dominates the medical-grade continuous glucose monitoring (CGM) market with a 40% share. The company holds 44.27% of patents for CGM devices, showcasing its strong innovation focus. Dexcom's products, such as the Dexcom G7, are renowned for their accuracy and user-friendly features. The company is set to launch Stelo, a new CGM designed for people with type 2 diabetes who do not use insulin, expected to hit the U.S. market in summer 2024. Dexcom anticipates total revenue of $4.15 billion to $4.35 billion for 2024, representing a 16% to 21% organic growth over 2023.

Medtronic Guardian

Medtronic's Guardian brand is a leading producer of continuous glucose monitoring (CGM) systems, known for its advanced technology and reliability. The Medtronic Guardian Sensor 4, for instance, requires no fingerstick calibrations and checks blood glucose levels every five minutes, integrating seamlessly with the MiniMed(tm) 780G system to predict and adjust insulin requirements. Introduced in 2004, the Guardian REAL-Time CGM system was a significant milestone, notifying users of potential hyperglycemia or hypoglycemia. Medtronic holds a notable market share in the glucose monitoring devices industry, with 10.15% of the patent analysis in this sector. The company's continuous innovations have made their CGM systems highly accurate and reliable for treatment decisions.

Roche Accu-Chek

Roche's Accu-Chek brand is a leading producer of blood sugar monitors, with the Accu-Chek Inform II holding a significant market share of 18.0% in 2023 in the U.S. point-of-care glucose testing market. This glucose meter is designed for in-vitro diagnostic procedures, accurately measuring blood glucose levels in various sample types, including capillary, venous, neonatal, arterial, and whole blood. It is widely adopted by healthcare professionals for its efficiency and ability to automate data management. In 2020, the Accu-Chek Inform II also held the largest revenue share of over 45.0% in the global Network Point-of-Care Glucose Testing market. The product's wireless meter and seamless IT integration enhance patient care by providing fast and reliable results.

LifeScan OneTouch

LifeScan's OneTouch brand is a leading global provider of blood glucose monitoring solutions, recognized for its innovative and user-friendly products. The OneTouch Verio Flex, for instance, was rated the Best Standard Glucose Meter of 2022 by Forbes Health due to its affordable test strips, color range indicator, and compact design. More than 20 million people worldwide rely on OneTouch brand products for managing their diabetes, with the brand being recommended by more endocrinologists and primary care physicians than any other. The OneTouch Reveal mobile app, connected to these meters, helps patients track and trend their blood sugar levels, contributing to better diabetes management and a 1% reduction in A1c levels in clinical studies. In the U.S., LifeScan is the leading blood glucose monitoring company, with significant market presence and sales.

Contour Next by Ascensia Diabetes Care

The Contour Next by Ascensia Diabetes Care is a highly acclaimed blood glucose monitoring system, renowned for its accuracy and user-friendly design. It features No Coding(r) technology, eliminating the need for manual calibration and reducing errors, as highlighted in a 2013 study published in the Journal of Diabetes Science and Technology. The system includes advanced features such as Second-Chance(r) sampling, which allows users to apply more blood to the same test strip within 60 seconds, enhancing accuracy and reducing waste. The Contour Next meters are also compatible with the CONTOUR(r)DIABETES app, enabling wireless data syncing and personalized target range tracking. This integration ensures comprehensive diabetes management and improves user compliance. For more details on the Contour Next blood glucose monitoring system, visit their website.

Omron

Omron Healthcare is a leading brand in the healthcare industry, particularly renowned for its high-quality blood pressure monitors and contributions to the glucose monitoring market. While Omron is not primarily known for blood sugar monitors, it is a dominant player in the digital blood pressure monitors market, holding a significant market share globally. In the broader context of healthcare devices, Omron's expertise and widespread distribution network, especially in the Asia Pacific region, contribute to its strong market presence. However, for blood glucose monitoring, other brands like Abbott Laboratories, Dexcom Inc., and Roche Holding AG are more prominent. Despite this, Omron's reputation for reliability and innovation makes it a trusted name in the healthcare technology sector.

iHealth

iHealth is a leading brand in the blood sugar monitoring market, known for its innovative and user-friendly products like the iHealth Gluco+ Wireless Smart Glucose Meter. This device has obtained FDA 510K clearance and CE certification, ensuring strict adherence to global standards for accuracy and reliability. It offers a comprehensive solution for proactive glucose management through the iGluco app, allowing users to store, track, and share their blood glucose readings. The market for self-monitoring blood glucose devices, which includes iHealth products, is expected to grow significantly, with the U.S. market projected to reach USD 7.14 billion by 2032, growing at a CAGR of 6.5% from 2024 to 2032. The iHealth Gluco+ requires only 0.7 microliters of blood and provides results in just 5 seconds.

ForaCare

ForaCare is a notable producer of blood sugar monitors, although it is not as prominently mentioned in recent market insights as other major players like Dexcom, Abbott, and Medtronic. However, ForaCare devices are recognized for their accuracy and user-friendly design, contributing to the growing demand in the blood glucose monitoring market, which is expected to reach USD 52.46 Billion by 2029 with a CAGR of 12%. The market growth is driven by increasing adoption of self-testing devices and government reimbursements. In the global context, Asia Pacific is projected to register the highest CAGR due to rising patient awareness and increasing healthcare spending. ForaCare's products align with industry standards, such as providing accurate readings within specified ranges like 70 to 180 mg/dL for Time in Range (TIR).

DarioHealth

DarioHealth is a leading provider of innovative blood sugar monitoring solutions, renowned for its all-in-one Dario™ Blood Glucose Monitoring System. This system, which received U.S. FDA clearance in December 2015, combines a compact meter, lancing device, and test strips, connecting to smartphones via a headphone jack to provide real-time and historical blood glucose data. By the end of September 2016, over 10,000 Dario devices were purchased in the U.S., with more than 5,500 sold in the third quarter alone, demonstrating significant market traction. The Dario app and platform support proactive diabetes management, with features like carb counting, health metric tracking, and personalized care plans, leading to improved A1c levels in users, particularly those with initial A1c levels above 9%. Approximately 65% of the total strips sold were purchased under the company's subscription plan, contributing to a robust recurring revenue model.